Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News Out

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon May 02, 2024 11:09pm

186 Views

Post# 36020947

RE:RE:News Out

Because like I said years ago, the clinical team doesn't appear to be adequate to handle a trial of this magnitude, which is evident by the sloppiness of the trial (not treating the first 12 correctly, not planning enough money, not having the enrollment expected, not expecting 450 day data)

Dont even get me started on the "GLP" studies, if I had to guess they won't get done until 2026, btw no mention of them

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide